Filter by ContentType
Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes
Marc Struhalla, Svenja Michalek
26 March 2025
Innovator Insight
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings
Kasey Kime, Xiao Peng
20 March 2025
Innovator Insight
Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells
Mark Kennedy, Marcus Bunn
10 March 2025
Innovator Insight
Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy
Phil Morton, Shanya Jiang
03 March 2025
Innovator Insight
Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors
J Hengst, Q Rafiq, R Ladi et al
27 February 2025
Innovator Insight
Robotic gloveless isolator technology enhances regional production of advanced therapeutics
Zach Hartman, Peter Boman
27 February 2025
Innovator Insight
Achieving robust and scalable AAV empty/full capsid separation for gene therapy
Julio Huato, Mark Schofield
26 February 2025
Innovator Insight
Maximizing cell therapy process flexibility and efficiency with next-generation technologies
19 February 2025
Innovator Insight
Speeding to success: accelerating cell therapy development and manufacturing workflows
17 February 2025
Innovator Insight
Toward clinical-scale nonviral gene-edited CAR-NK cells for cell therapy
Namritha Ravinder, Krishanu Saha
13 February 2025
Innovator Insight
Make more lentivirus and make it right the first time
Katherine Schewe
10 February 2025
Innovator Insight
Enhancing CAR-T therapy development: harnessing cell selection flexibility
Tamara Laskowski, Nuala Trainor
06 February 2025
Innovator Insight
Optimizing for the future: streamlining the production of T cell-based immunotherapies
Soong Poh Loong, Paula Lam
28 January 2025
Innovator Insight
Closed system solutions for cell and gene therapy manufacturing
Anette Funfak
05 December 2024
Innovator Insight
Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance
Edward Grimley, Leanne Kodsmann
04 December 2024
Innovator Insight
Generation of novel AAV serotypes with enhanced infectivity, specificity, and lower toxicity via AAV capsid engineering platform
Y Bu, Y Pan, Y Zhong et al
03 December 2024
Innovator Insight
From the lab to the bench: scaling up regulatory T cell therapy
Megan Levings, Hany Meås
26 November 2024
Innovator Insight
Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy
Therese Choquette, Minh Ngoc Duong
25 November 2024
Innovator Insight
AAV downstream challenges: expert insights
N Clement, W Kish, N Laroudie et al
04 November 2024
Innovator Insight
Optimizing bioprocess purification: effective nucleic acid removal in high salt environments
Eleonora Turco, Joanna Niska-Blakie
30 October 2024
Innovator Insight
Extracellular vesicles: setting your path to IND with advanced characterization packages
Davide Zocco
28 October 2024
Innovator Insight